1. IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T‐CELL PROJECT. (June 2017) Authors: Fox, C.P.; Bellei, M.; Manni, M.; Kim, S.J.; Ko, Y.H.; Shustov, A.R.; Cabrera, M.E.; Chiattone, C.S.; Horwitz, S.M.; Spina, M.; Advani, R.H.; Angrilli, F.; De Souza, C.A.; Dlouhy, I.; Fernandez‐Alvarez, R.; Gabús, R.; Hitz, F.; Laszlo, D.; Montoto, S.; Nagler, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R‐CVP WITH R‐CHOP AND R‐FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY. (June 2017) Authors: Luminari, S.; Tarantino, V.; Anastasia, A.; Boccomini, C.; Chiarenza, A.; Rigacci, L.; Angelucci, E.; Ferrari, A.; Pulsoni, A.; Rattotti, S.; Angrilli, F.; Gaidano, G.; Stelitano, C.; Bertoldero, G.; Cascavilla, N.; Salvi, F.; Ferreri, A.J.; Vallisa, D.; Balzarotti, M.; Cox, M.C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL. (June 2017) Authors: Luminari, S.; Marcheselli, L.; Manni, M.; Anastasia, A.; Vitolo, U.; Chiarenza, A.; Rigacci, L.; Angelucci, E.; Fama, A.; Pulsoni, A.; Rattotti, S.; Angrilli, F.; Gaidano, G.; Stelitano, C.; Bertoldero, G.; Cascavilla, N.; Salvi, F.; Ferreri, A.J.; Tarantino, V.; Bellei, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗